Eocene Ltd. (EOCN) Stock Price & Analysis
Eocene Ltd. (EOCN) closed at USD 3.05 on Thursday, October 15, 2026, up 1.33% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 3.01; the Oct 15, 2026 session ranged USD 2.92–3.06 on volume of 1,899 shares. Market capitalization is $3.26M, with a 52-week range of USD 2.67–12.32 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/EOCN.md
Key facts (EOCN)
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts).
- Total return with dividends: 1Y -73.0% vs S&P 500 +18.1%; 5Y -99.9% vs S&P 500 +85.1%.
Analysts (EOCN)
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts.
Total return (dividends reinvested) (EOCN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -73.0% | -99.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -73.1% | -76.1% |
| Volatility (annualized) | 95.8% | 106.9% |
| Max drawdown | -74.4% (Oct 2025→Oct 2026) | -99.9% (Nov 2021→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:49 UTC)
| Price | USD 3.05 |
|---|---|
| Change | ▲ 1.33% (up) |
| Previous Close | USD 3.01 |
| Open | USD 2.92 |
| Day Range | USD 2.92 – 3.06 |
| 52-Week Range | USD 2.67 – 12.32 |
| Volume | 1,899 shares |
| Market Cap | $3.26M |
| Exchange | NCM |
Technical Analysis (EOCN)
Nexqual's technical model rates EOCN "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:49 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.17 (neutral) |
| vs SMA50 | Below (USD 3.89) |
| MACD | -0.2 (negative) |
Analyst Ratings (EOCN)
Wall Street analysts rate EOCN "Hold" based on 1 analysts, per Nexqual as of October 16, 2026 at 05:49 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (EOCN)
| Revenue Estimate | $0 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -2.86 vs est -3.12 ▲ beat |
| 2026-03-31 | USD -2.32 vs est -3.04 ▲ beat |
| 2025-12-31 | USD -7.36 vs est -4.08 ▼ miss |
| 2025-09-30 | USD -2.64 vs est -4.32 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Financials & Fundamentals (EOCN)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -68.21% |
| Debt / Equity | 0.01 |
| Current Ratio | 4.16 |
| Total Cash | $11.23M |
| Total Debt | $129,000 |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Financial Health Score (EOCN)
Nexqual rates Eocene Ltd.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:49 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $11M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$9M (TTM) |
| Efficiency | Critical — ROE -68%, ROA -30.2% |
Ownership (EOCN)
| Insider Ownership | +3.04% |
|---|---|
| Institutional Ownership | +1.89% |
| Shares Outstanding | 1.07M |
| Float | 977,020 |
| Short % of Float | +1.35% |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Leadership (EOCN)
Eocene Ltd. is led by Allen Baharaff (age 60), Co-Founder, President, CEO & Chairman, per Nexqual as of October 16, 2026 at 05:49 UTC.
| Co-Founder, President, CEO & Chairman | Allen Baharaff (age 60) |
|---|---|
| Chief Financial Officer | Doron Cohen (age 58) |
| COO & Data Protection Officer | Guy Nehemya (age 40) |
| Chief Scientific Officer | Liat Hayardeny (age 58) |
Major Backers & Investors (EOCN)
Notable institutional backers of Eocene Ltd. include Citadel, HRT Financial LP, Xtx Topco Ltd, according to Nexqual as of October 16, 2026 at 05:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Citadel | 1.04% |
| HRT Financial LP | 0.51% |
| Xtx Topco Ltd | 0.18% |
| Delaware Group Equity Funds IV-Nomura Healthcare Fund | 0.16% |
| Two Sigma Securities, LLC | 0.13% |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 87.97 | ▲ 1.57% |
| BLTE | Belite Bio, Inc | USD 152.62 | ▲ 0.49% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.72 | ▲ 1.52% |
| PRAX | Praxis Precision Medicines, Inc | USD 248.24 | ▲ 2.01% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 44.12 | ▲ 4.11% |
| SYRE | Spyre Therapeutics, Inc. | USD 80.1 | ▼ 0.44% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt